908 Devices (MASS) Stock: Buy, Sell, or Hold?
MASS - 908 Devices Inc. Common Stock
$9.52
0.17 (1.82%)
â˛
5d:
-5.18%
30d:
-4.99%
90d:
+15.82%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When MASS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MASS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MASS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MASS is currently trading at $9.52, which is considered slightly low relative to its 30-day fair value range of $9.18 to $10.73.
Technical Outlook: Technically, MASS is in a strong uptrend. The price is currently testing key support at $9.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASS scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.12 (+37.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MASS is in a strong uptrend. The price is currently testing key support at $9.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: MASS scores 24/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.12 (+37.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$9.18 -
$10.73
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (24/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 37.9% below Wall St target ($13.12)
- WARNING: Composite score 44/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.18 -
$10.73
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$9.32
Resistance Level
$11.05
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-31.73
Wall Street Target
$13.13
(+37.9%)
Revenue Growth (YoY)
23.3%
Profit Margin
-57.0%
Share & Embed Analysis
Last updated: September 12, 2026 9:22 PM ET
Data refreshes hourly during market hours. Next update: 10:22 PM
Data refreshes hourly during market hours. Next update: 10:22 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MASS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher D Brown
SELL
17578 shares
2026-04-10
Kevin J Mccallion
SELL
2693 shares
2026-04-10
Christopher D Brown
SELL
7392 shares
2026-04-09
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
ZBH
Zimmer Biomet Holdings IâĻ |
HOLD
29 analysts |
$108 | 50 HOLD |
